US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Summit Hotel Properties

4.07

+0.09002.26%

Post-market: 4.070.00000.00%16:05 EDT

Volume:1.12M

Turnover:4.53M

Market Cap:453.32M

PE:18.48

High:4.09

Open:3.97

Low:3.96

Close:3.98

Loading ...

Overview Company News Filings

Actinogen reports busy 6 months as development of Xanamem molecule ramps up

The Market Herald

Summit Hotel Properties Inc expected to post a loss of 10 cents a share - Earnings Preview

Park Hotels & Resorts (PK) Q4 FFO Miss Estimates

Chemomab Completes Successful End-of-Phase 2 Meeting and Aligns with FDA on Clear and Efficient Path to Potential Regulatory Approval for Nebokitug (CM-101) in Primary Sclerosing Cholangitis

Longeveron® Announces World Health Organization Approval of “laromestrocel” as International Non-proprietary Name for Stem Cell Therapy Lomecel-B™

Summit Hotel Properties (INN): Among the Best Hotel Stocks to Buy According to Analysts

Innocan Pharma's Liposomal CBD Injection Shows Breakthrough Pain Relief in Elderly Donkey with Osteoarthritis

Actinogen announces new and unique nonproprietary name of 'emestedastat' for Xanamem

Innocan Pharma's Subsidiary BI Sky Global Completes HRIPT Testing and Surpasses Important Sales Milestone

BofA Securities Adjusts Summit Hotel Properties Price Target to $7 From $6.50

MT Newswires Live

Summit Hotel Properties Keeps Quarterly Dividend at $0.08 a Share, Payable Feb. 28 to Holders of Record Feb. 14

MT Newswires Live

Press Release: SUMMIT HOTEL PROPERTIES DECLARES FOURTH QUARTER 2024 DIVIDENDS

Mersana Therapeutics Announces Additional FDA Fast Track Designation Granted to Emiltatug Ledadotin (XMT-1660)

SUMMIT HOTEL PROPERTIES ANNOUNCES FOURTH QUARTER AND FULL YEAR 2024 EARNINGS RELEASE DATE

FDA's Center for Veterinary Medicine Grants Innocan Pharma a Fee Waiver for 2025

SELLAS Announces Key Business Objectives for 2025

Innocan Pharma Announces Closing of Private Placement for Gross Proceeds of C$635,444.60

Precigen Completes Submission of BLA with Request for Priority Review to the FDA for PRGN-2012 for the Treatment of Adults with Recurrent Respiratory Papillomatosis

Innocan Pharma Announces Private Placement of Units

Innocan Pharma Provides its Annual "State of Research and Development" Update for 2024

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/INN/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"INN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INN\",,,,,undefined,":{"symbol":"INN","market":"US","secType":"STK","nameCN":"Summit Hotel Properties","latestPrice":4.07,"timestamp":1745870400000,"preClose":3.98,"halted":0,"volume":1123835,"hourTrading":{"tag":"盘后","latestPrice":4.07,"preClose":4.07,"latestTime":"16:05 EDT","volume":25878,"amount":105323.46,"timestamp":1745870711477},"delay":0,"floatShares":98129831,"shares":111381527,"eps":0.220269,"marketStatus":"Post-Mkt","change":0.09,"latestTime":"04-28 19:59:51 EDT","open":3.97,"high":4.085,"low":3.96,"amount":4532303.495143,"amplitude":0.031407,"askPrice":4.78,"askSize":100,"bidPrice":3.21,"bidSize":100,"shortable":3,"etf":0,"ttmEps":0.220269,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1745884800000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1297227600000,"exchange":"NYSE","adjPreClose":3.98,"dividendRate":0.07371,"postHourTrading":{"tag":"盘后","latestPrice":4.07,"preClose":4.07,"latestTime":"16:05 EDT","volume":25878,"amount":105323.46,"timestamp":1745870711477},"volumeRatio":1.259757,"impliedVol":1.1727,"impliedVolPercentile":0.924},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INN\",,,,,undefined,":{"symbol":"INN","floatShares":98129831,"roa":"1.74%","roe":"2.80%","lyrEps":0.237342,"volumeRatio":1.259757,"shares":111381527,"dividePrice":0.3,"high":4.085,"amplitude":0.031407,"preClose":3.98,"low":3.96,"week52Low":3.57,"pbRate":"0.50","psRate":"0.62","week52High":7.22,"institutionHeld":0,"latestPrice":4.07,"eps":0.220269,"divideRate":0.07371,"volume":1123835,"delay":0,"ttmEps":0.220269,"open":3.97,"prevYearClose":6.85,"prevWeekClose":3.98,"prevMonthClose":5.41,"prevQuarterClose":5.41,"fiveDayClose":3.86,"twentyDayClose":5.4,"sixtyDayClose":6.76,"earningDate":1745942400000,"earningTime":"盘后"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"INN\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2513173697","title":"Actinogen reports busy 6 months as development of Xanamem molecule ramps up","url":"https://stock-news.laohu8.com/highlight/detail?id=2513173697","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513173697?lang=en_us&edition=fundamental","pubTime":"2025-02-24 13:59","pubTimestamp":1740376740,"startTime":"0","endTime":"0","summary":"Actinogen Medical Ltd  said its net loss after tax for the six months to December 2024 decreased by 29% to $8,168,979 – compared to $11,556,659 in the HY24 – largely based on the ramping up of development activity for lead molecule Xanamem, intended for treatment of Alzheimer’s disease and depression.Research and development costs – mainly relating to clinical trials – accounted for the main expenditure item, with these costs being $4.58 million.Actinogen reported a busy and successful year in terms of these trials, including ongoing progress in screening and enrolment for its XanaMIA phase 2b/3 Alzheimer’s disease  trial, and positive findings yielded from its completed XanaCIDD phase 2a major depressive disorder  trial.Results from the latter included positive findings on depressive symptoms – with this supporting the theory that controlling cortisol can have clinical benefits.The material provided in this article is for information only and should not be treated as investment advice","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/actinogen-reports-busy-6-months-as-development-of-xanamem-molecule-ramps-up-2025-02-24/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["BK4218","INN","ACW.AU","BK7067","BK4181","BK7508"],"gpt_icon":0},{"id":"2513438532","title":"Summit Hotel Properties Inc  expected to post a loss of 10 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2513438532","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513438532?lang=en_us&edition=fundamental","pubTime":"2025-02-22 06:12","pubTimestamp":1740175926,"startTime":"0","endTime":"0","summary":"Summit Hotel Properties Inc  expected to post a loss of10cents a share - Earnings Preview Summit Hotel Properties Inc INN.N, INN is expected to show a fall in quarterly revenue when it reports  result","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250221:nL5N3PC2D5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INN"],"gpt_icon":0},{"id":"2512459941","title":"Park Hotels & Resorts (PK) Q4 FFO Miss Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2512459941","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512459941?lang=en_us&edition=fundamental","pubTime":"2025-02-20 06:30","pubTimestamp":1740004207,"startTime":"0","endTime":"0","summary":"Park Hotels & Resorts  came out with quarterly funds from operations  of $0.39 per share, missing the Zacks Consensus Estimate of $0.40 per share. This compares to FFO of $0.52 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an FFO surprise of -2.50%. A quarter ago, it was expected that this company would post FFO of $0.49 per share when it actually produced FFO of $0.49, delivering no surprise.Park Hotels & Resorts , which belongs to the Zacks REIT and Equity Trust - Other industry, posted revenues of $625 million for the quarter ended December 2024, surpassing the Zacks Consensus Estimate by 3.66%. This compares to year-ago revenues of $657 million. The company has topped consensus revenue estimates two times over the last four quarters.Park Hotels & Resorts shares have lost about 6.5% since the beginning of the year versus the S&P 500's gain of 4.2%.While Park Hotels & Resorts has underperformed the market so far this year, t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/park-hotels-resorts-pk-q4-223007646.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["INN","BK4181","BK4218","PK"],"gpt_icon":0},{"id":"2512051221","title":"Chemomab Completes Successful End-of-Phase 2 Meeting and Aligns with FDA on Clear and Efficient Path to Potential Regulatory Approval for Nebokitug (CM-101) in Primary Sclerosing Cholangitis","url":"https://stock-news.laohu8.com/highlight/detail?id=2512051221","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512051221?lang=en_us&edition=fundamental","pubTime":"2025-02-19 20:00","pubTimestamp":1739966400,"startTime":"0","endTime":"0","summary":"Single Positive Phase 3 Trial Designed to Support Full Regulatory Approval, For the First Time Providing Regulatory Clarity in PSC and Positioning Nebokitug to Potentially Become the First FDA-Approved Treatment for PSC. No Liver Biopsies or Additional Confirmatory Studies Required—Phase 3 Trial Endpoint Is Based onWell-Characterized Clinical Events Associated with PSC Disease Progression. Advancing Discussions with Potential Strategic Partners Post-FDA Feedback While Preparingfor Nebokitug Phase 3 Trial. Dr. Mor continued, “Importantly, key publications have shown that the reductions in PSC biomarkers in our nebokitug Phase 2 SPRING trial, especially the Enhanced Liver Fibrosis  and liver stiffness elastography measures, are associated with reductions in clinical events, increasing our confidence in the relevance of this approach for nebokitug and decreasing risk. We are looking forward to reporting topline data from the open label extension portion of the SPRING trial, which is prima","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/chemomab-completes-successful-end-phase-120000353.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0566484027.USD","BK4207","CM","LU0979878070.USD","BK4218","BK4181","LU1242518857.USD","CMMB","LU1559883803.SGD","BK4183","LU0053671581.USD","BK4585","PSC","INN","LU1242518931.SGD","ELF","BK4588","BK4139"],"gpt_icon":0},{"id":"2512165917","title":"Longeveron® Announces World Health Organization Approval of “laromestrocel” as International Non-proprietary Name for Stem Cell Therapy Lomecel-B™","url":"https://stock-news.laohu8.com/highlight/detail?id=2512165917","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512165917?lang=en_us&edition=fundamental","pubTime":"2025-02-18 22:25","pubTimestamp":1739888700,"startTime":"0","endTime":"0","summary":"Wa'el Hashad   Wa'el Hashad, CEO, Longeveron  Cellular therapy Lomecel-B has been granted an International Non-proprietary Name (INN) of “laromestrocel” on the INN List issued by the World Health Orga","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/18/3027989/0/en/Longeveron-Announces-World-Health-Organization-Approval-of-laromestrocel-as-International-Non-proprietary-Name-for-Stem-Cell-Therapy-Lomecel-B.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4150","BK4218","BK4139","INN","BK4181","MSC","LGVN","BK4575"],"gpt_icon":0},{"id":"2512889950","title":"Summit Hotel Properties (INN): Among the Best Hotel Stocks to Buy According to Analysts","url":"https://stock-news.laohu8.com/highlight/detail?id=2512889950","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512889950?lang=en_us&edition=fundamental","pubTime":"2025-02-17 05:52","pubTimestamp":1739742765,"startTime":"0","endTime":"0","summary":"We recently published a list of the 12 Best Hotel Stocks To Buy According to Analysts. In this article, we are going to take a look at where Summit Hotel Properties, Inc.  stands against other best hotel stocks to buy according to analysts.The hospitality industry is undergoing a significant transformation after the post-Covid travel rebound. According to a report by Zion Market Research, the global hotel market is valued at $1.37 trillion as of 2023. It is expected to reach $2.99 trillion by 2032, growing at a compound annual growth rate of 9.14% between 2024 and 2032. This growth is attributed to the surging travel demand post-Covid, resurgence in leisure and business activities, and increased disposable incomes.We sifted through stock screeners, online rankings, and ETFs to compile a list of 30 hotel stocks. We checked their upside potential, according to analysts, and then selected the top 12 most popular stocks among elite hedge funds as of Q3 2024. We sourced the hedge fund senti","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/summit-hotel-properties-inn-among-215245473.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4181","INN","BK4218"],"gpt_icon":0},{"id":"2510897701","title":"Innocan Pharma's Liposomal CBD Injection Shows Breakthrough Pain Relief in Elderly Donkey with Osteoarthritis","url":"https://stock-news.laohu8.com/highlight/detail?id=2510897701","media":"CNW Group","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510897701?lang=en_us&edition=fundamental","pubTime":"2025-02-11 05:00","pubTimestamp":1739221200,"startTime":"0","endTime":"0","summary":"This is the second successful treatment in a donkey, demonstrating the potential of Innocan's Liposomal CBD injection for human and veterinary use. Ariel, a 35-year-old elderly female donkey residing at a rescue farm, had endured years of carrying excessive weight, leading to debilitating osteoarthritis across multiple joints. The chronic pain severely limited her mobility, affecting her overall well-being.As an act of compassionate therapy, Ariel was administered a single LPT-CBD injection. Positive effects were observed, and Ariel mobility was improved for several weeks. Due to the remarkable success of the treatment, she was given a second LPT-CBD dose, which demonstrated continued improvement in her condition.Innocan is an innovator in the pharmaceuticals and wellness sectors. In the pharmaceuticals sector, Innocan developed a CBD-loaded liposome drug delivery platform with exact dosing, prolonged and controlled release of synthetic CBD for non-opioid pain management. In the wellne","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/innocan-pharmas-liposomal-cbd-injection-210000599.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4557","INNPF","BK4007","BK4218","BK4113","ACB","INN","BK4181","CBD"],"gpt_icon":1},{"id":"2509284832","title":"Actinogen announces new and unique nonproprietary name of 'emestedastat' for Xanamem","url":"https://stock-news.laohu8.com/highlight/detail?id=2509284832","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509284832?lang=en_us&edition=fundamental","pubTime":"2025-02-05 22:18","pubTimestamp":1738765080,"startTime":"0","endTime":"0","summary":"Late-stage Alzheimer's trial opens 10 new sites in USA, with results due in 2025 and 2026. SYDNEY, Feb. 5, 2025 /PRNewswire/ -- Actinogen Medical Limited  announces that the World Health Organization  has granted the nonproprietary name of 'emestedastat' to Actinogen for its Xanamem/UE2343 once-a-day small molecule in accordance with the WHO's Procedure for the Selection of Recommended International Nonproprietary Names  for Pharmaceutical Substances.The XanaMIA phase 2b/3 clinical trial in patients with biomarker-positive mild to moderate Alzheimer's disease  is picking up pace as clinical sites ramp up activity with all 25 sites now actively pre-screening potential trial participants. More than 300 people have been pre-screened with a blood pTau test and approximately 40 have entered the 36-week treatment phase of the trial. Final results are expected in the second half of 2026 with interim results[1] anticipated in Q4 this year.The XanaMIA AD trial is enrolling 220 participants with","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance_au","url":"https://finance.yahoo.com/news/actinogen-announces-unique-nonproprietary-name-141800289.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/actinogen-announces-unique-nonproprietary-name-141800289.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK7067","BK4218","ACW.AU","INN","BK7508","BK4181"],"gpt_icon":0},{"id":"2507665979","title":"Innocan Pharma's Subsidiary BI Sky Global Completes HRIPT Testing and Surpasses Important Sales Milestone","url":"https://stock-news.laohu8.com/highlight/detail?id=2507665979","media":"CNW Group","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507665979?lang=en_us&edition=fundamental","pubTime":"2025-01-30 05:01","pubTimestamp":1738184460,"startTime":"0","endTime":"0","summary":"HERZLIYA, Israel and CALGARY,AB, Jan. 29, 2025 /CNW/ -- Innocan Pharma Corporation    , a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce that its subsidiary, BI Sky Global , successfully completed the Human Repeated Insult Patch Test  for Sensitization and Irritation Testing, ensuring the safety of its cosmetic products. HRIPT is the personal care industry's standard safety test for cosmetic, OTC drug, and topical medical devices.In addition, the Company announced that it has surpassed the important sales milestone of an average of 5,000 units per day in 2024. This achievement is particularly significant as the typical minimum production quantity for most cosmetic products is 5,000 units in total, while BI Sky Global sells this amount daily. This significant sales volume far exceeds the requirements for annual production agreements with key third-party manufacturing companies.Iris Bincovich, CEO of Innocan Pharma, added: \"This is further clear eviden","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/innocan-pharmas-subsidiary-bi-sky-210100932.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["INN"],"gpt_icon":0},{"id":"2506530191","title":"BofA Securities Adjusts Summit Hotel Properties Price Target to $7 From $6.50","url":"https://stock-news.laohu8.com/highlight/detail?id=2506530191","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506530191?lang=en_us&edition=fundamental","pubTime":"2025-01-27 23:58","pubTimestamp":1737993484,"startTime":"0","endTime":"0","summary":"Summit Hotel Properties (INN) has an average rating of Hold and mean price target of $7.88, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from ma","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["INN"],"gpt_icon":0},{"id":"2505186022","title":"Summit Hotel Properties Keeps Quarterly Dividend at $0.08 a Share, Payable Feb. 28 to Holders of Record Feb. 14","url":"https://stock-news.laohu8.com/highlight/detail?id=2505186022","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505186022?lang=en_us&edition=fundamental","pubTime":"2025-01-24 06:36","pubTimestamp":1737671812,"startTime":"0","endTime":"0","summary":"Summit Hotel Properties Keeps Quarterly Dividend at $0.08 a Share, Payable Feb. 28 to Holders of Record Feb. 14","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["INN"],"gpt_icon":0},{"id":"2505024367","title":"Press Release: SUMMIT HOTEL PROPERTIES DECLARES FOURTH QUARTER 2024 DIVIDENDS","url":"https://stock-news.laohu8.com/highlight/detail?id=2505024367","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505024367?lang=en_us&edition=fundamental","pubTime":"2025-01-24 06:00","pubTimestamp":1737669600,"startTime":"0","endTime":"0","summary":"AUSTIN, Texas, Jan. 23, 2025 /PRNewswire/ -- Summit Hotel Properties, Inc.  , announced today that its Board of Directors has authorized, and the Company has declared, a cash dividend for the fourth quarter ended December 31, 2024, of $0.08 per share of common stock of the Company and per common unit of limited partnership interest in Summit Hotel OP, LP, the Company's operating partnership. The Company's fourth quarter common dividend represents an annualized dividend yield of 4.8 percent based on the closing price of shares of the common stock on January 22, 2025.The Board of Directors has also authorized, and the Company has declared, a cash dividend of $0.390625 per share of the Company's 6.25% Series E Cumulative Redeemable Preferred Stock for the dividend period ending on February 28, 2025, and a cash dividend of $0.3671875 per share of the Company's 5.875% Series F Cumulative Redeemable Preferred Stock for the dividend period ending on February 28, 2025.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["H15.SI","BK4218","INN","BK6505","BK4181","BK6059"],"gpt_icon":0},{"id":"2502856578","title":"Mersana Therapeutics Announces Additional FDA Fast Track Designation Granted to Emiltatug Ledadotin (XMT-1660)","url":"https://stock-news.laohu8.com/highlight/detail?id=2502856578","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502856578?lang=en_us&edition=fundamental","pubTime":"2025-01-10 19:02","pubTimestamp":1736506920,"startTime":"0","endTime":"0","summary":"Conference call to discuss positive initial Phase 1 clinical data today at 8:30 a.m. ETCAMBRIDGE, Mass., Jan.  10, 2025  (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/01/10/3007496/0/en/Mersana-Therapeutics-Announces-Additional-FDA-Fast-Track-Designation-Granted-to-Emiltatug-Ledadotin-XMT-1660.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00BYQQ9H92.USD","IE00B5TLWC47.USD","BK4585","BK4218","IE00BFXG0V08.USD","BK4563","FAST","LENZ","BK4181","BK4104","BK4567","INN","MRSN","BK4139"],"gpt_icon":0},{"id":"2502207990","title":"SUMMIT HOTEL PROPERTIES ANNOUNCES FOURTH QUARTER AND FULL YEAR 2024 EARNINGS RELEASE DATE","url":"https://stock-news.laohu8.com/highlight/detail?id=2502207990","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502207990?lang=en_us&edition=fundamental","pubTime":"2025-01-10 06:00","pubTimestamp":1736460000,"startTime":"0","endTime":"0","summary":"AUSTIN, Texas, Jan. 9, 2025 /PRNewswire/ -- Summit Hotel Properties, Inc.   today announced that it will report financial results for the fourth quarter and full year of 2024 on Monday, February 24, 2025, after the market closes.The Company will conduct its quarterly conference call on Tuesday, February 25, 2025, at 9:00 AM ET.To access the conference call, please pre-register using this link. Registrants will receive a confirmation with dial-in details.A live webcast of the conference call can be accessed using this link. A replay of the webcast will be available in the Investors section of the Company's website, www.shpreit.com, until April 30, 2025.Summit Hotel Properties, Inc. is a publicly traded real estate investment trust focused on owning premium-branded lodging facilities with efficient operating models primarily in the upscale segment of the lodging industry. As of January9, 2025, the Company's portfolio consisted of 97 assets, 53 of which are wholly owned, with a total of 1","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/summit-hotel-properties-announces-fourth-220000961.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/summit-hotel-properties-announces-fourth-220000961.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["YEAR","INN"],"gpt_icon":0},{"id":"2502020760","title":"FDA's Center for Veterinary Medicine Grants Innocan Pharma a Fee Waiver for 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2502020760","media":"CNW Group","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502020760?lang=en_us&edition=fundamental","pubTime":"2025-01-10 05:01","pubTimestamp":1736456460,"startTime":"0","endTime":"0","summary":"HERZLIYA, Israel and CALGARY, Alberta, Jan. 9, 2025 /CNW/ -- Innocan Pharma Corporation    , a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce that the FDA's Center for Veterinary Medicine  has granted the Company a sponsor fee waiver for its LPT-CBD  product for the second consecutive year.The Animal Drug User Fee Act  authorizes the FDA's Center for Veterinary Medicine  to collect user fees for certain animal drug applications on an annual basis. Under this Act, sponsors may request a yearly fee waiver through the 'significant barrier to innovation' provision. Following a thorough review, the CVM granted Innocan the 2025 fee waiver, recognizing the Company's continued pursuit of innovative animal drug products and technology.Dr. Eyal Kalo, R&D Director at Innocan further added, \"The fee waiver granted by the Center for Veterinary Medicine  for the second time underscores their continued recognition and support of our efforts to advance LPT-CBD devel","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fdas-center-veterinary-medicine-grants-210100877.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["INNPF","CVM","BK4181","BK4007","BK4218","BK4557","INN","ACB","BK4139"],"gpt_icon":0},{"id":"2501772285","title":"SELLAS Announces Key Business Objectives for 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2501772285","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501772285?lang=en_us&edition=fundamental","pubTime":"2025-01-08 21:20","pubTimestamp":1736342400,"startTime":"0","endTime":"0","summary":"- Independent Data Monitoring Committee to Perform Interim Analysis of Phase 3 REGAL Study in January 2025 - - SLS009: Full Topline Phase 2 Data in Acute Myeloid Leukemia and FDA Regulatory Review Exp","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/01/08/3006252/0/en/SELLAS-Announces-Key-Business-Objectives-for-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALL","LU2355687059.USD","ASH","BK4107","SLS","INN","LU1699723380.USD","BK4202","LU0985320562.USD","LU1571399168.USD","BK4183","BK4533","LU2463526074.USD","NCI","BK4218","ODD","BK4181","BK4585","BK4588","BK4109"],"gpt_icon":0},{"id":"2500298629","title":"Innocan Pharma Announces Closing of Private Placement for Gross Proceeds of C$635,444.60","url":"https://stock-news.laohu8.com/highlight/detail?id=2500298629","media":"CNW Group","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500298629?lang=en_us&edition=fundamental","pubTime":"2025-01-01 05:01","pubTimestamp":1735678860,"startTime":"0","endTime":"0","summary":"Each Unit is comprised of one common share of the Company  and one common share purchase warrant of the Company . Each Warrant will entitle the holder thereof to purchase one Common Share at an exercise price of C$0.28 for a period of four  years from the date of issuance.The Company paid an arm's length finder a cash fee of C$13,500 and issued to the finder 67,500 warrants attributable to investors introduced to the Company by the finder within 3 months following such introduction . Each Finder Warrant entitles the Finder to purchase one Common Share at an exercise price of C$0.28 for a period of four  years from the date of issuance.Innocan is an innovator in the pharmaceuticals and wellness sectors. In the pharmaceuticals sector, Innocan developed a CBD-loaded liposome drug delivery platform with exact dosing, prolonged and controlled release of synthetic CBD for non-opioid pain management. In the wellness sector, Innocan develops and markets a wide portfol","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/innocan-pharma-announces-closing-private-210100046.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["INNPF","BK4181","BK4007","BK4218","LPT","INN"],"gpt_icon":0},{"id":"2495545521","title":"Precigen Completes Submission of BLA with Request for Priority Review to the FDA for PRGN-2012 for the Treatment of Adults with Recurrent Respiratory Papillomatosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2495545521","media":"PR Newswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495545521?lang=en_us&edition=fundamental","pubTime":"2024-12-30 20:00","pubTimestamp":1735560000,"startTime":"0","endTime":"0","summary":"– PRGN-2012 has the potential to be the first FDA-approved therapeutic for the treatment of adults with RRP, a rare and devastating chronic disease for which the current standard-of-care is repeated surgeries – – PRGN-2012 received Breakthrough Therapy Designation from the FDA and Orphan Drug Designation from the FDA and the European Commission –– The BLA, under an accelerated approval pathway, is supported by data from the Phase 1/2 pivotal study in which more than 50% of patients achieved Complete Response and more than 85% of patients had a decrease in surgical interventions in the year after PRGN-2012 treatment compared to the year prior to treatment –– PRGN-2012 was well-tolerated with no dose-limiting toxicities and no treatment-related adverse events greater than Grade 2 –。PRGN-2012 is an investigational AdenoVerse gene therapy designed to elicit immune responses directed against cells infected with human papillomavirus  6 or HPV 11. PRGN-2012 received Breakthrough Therapy Desig","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/precigen-completes-submission-bla-request-120000584.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/precigen-completes-submission-bla-request-120000584.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4218","BK4181","PGEN","INN","BK4139"],"gpt_icon":0},{"id":"2492487718","title":"Innocan Pharma Announces Private Placement of Units","url":"https://stock-news.laohu8.com/highlight/detail?id=2492487718","media":"CNW Group","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492487718?lang=en_us&edition=fundamental","pubTime":"2024-12-20 05:33","pubTimestamp":1734643980,"startTime":"0","endTime":"0","summary":"HERZLIYA, Israel and CALGARY, AB, Dec. 19, 2024 /CNW/ -- Innocan Pharma Corporation     is pleased to announce that it intends to complete a non-brokered private placement of up to [3,500,000] units of the Company  at a price of [C$0.20] per Unit for gross proceeds up to C$700,000 plus 15% over allotment options . The Offering is expected to close on or around December 31, 2024.Each Unit will be comprised of:  one  common share in the capital of the Company ; and  one  common share purchase warrant . Each Warrant will entitle the holder thereof to purchase one Common Share at a price of [C$0.28] for a period of four  years from the date of issuance.Innocan intends to use the proceeds of the Offering for working capital and general corporate purposes.The securities issued to Canadian subscribers in connection with the Offering will be subject to a hold period of four months and one day from the date of issuance, in accordance with applicable Canadian securities laws.Certain information ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/0E.7l4y9jnds4XLTwEXGMQ--~B/aD0yODM7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/cnwgroup.com/7706f970d25ba77672f989a1db7cd166","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/0E.7l4y9jnds4XLTwEXGMQ--~B/aD0yODM7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/cnwgroup.com/7706f970d25ba77672f989a1db7cd166"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/innocan-pharma-announces-private-placement-213300689.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4181","INN","BK4218"],"gpt_icon":0},{"id":"2491936844","title":"Innocan Pharma Provides its Annual \"State of Research and Development\" Update for 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2491936844","media":"CNW Group","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491936844?lang=en_us&edition=fundamental","pubTime":"2024-12-13 05:01","pubTimestamp":1734037260,"startTime":"0","endTime":"0","summary":"HERZLIYA, Israel and CALGARY, Alberta, Dec. 12, 2024 /CNW/ -- Innocan Pharma Corporation     a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies and an owner of a proprietary intellectual property portfolio, is pleased to share its annual \"State of Research and Development\" update for 2024. This year, the Company achieved significant milestones in advancing research and development for its drug delivery platforms as well as its intellectual property portfolio.During 2024, Innocan achieved significant milestones in both scientific and regulatory domains. Preclinical studies of its liposome-cannabidiol technology (LPT-CBD( demonstrated high CBD bioavailability, along with long-lasting pain relief and improved well-being in various animal models. Building on this compelling data, the Company secured agreement from the United States Food and Drug Administration (FDA) on the preclinical and Phase 1 clinical development plan to advance LP","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/0E.7l4y9jnds4XLTwEXGMQ--~B/aD0yODM7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/cnwgroup.com/7706f970d25ba77672f989a1db7cd166","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/0E.7l4y9jnds4XLTwEXGMQ--~B/aD0yODM7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/cnwgroup.com/7706f970d25ba77672f989a1db7cd166"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/innocan-pharma-provides-annual-state-210100474.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B64PRP62.GBP","LU0061475181.USD","IE0034235188.USD","BK4585","INN","BK4135","IE00BGHQF748.EUR","LU1883839398.USD","ACB","BK4588","BK4218","IE00B3QW5Z07.USD","BK4181","CVM","STT","INNPF","BK4557","BK4139","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":80,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/INN\",params:#limit:5,,,undefined,":[{"date":"2025-05-16","symbol":"INN","amount":0.08,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-16","defaultRemindTime":1747402200000,"name":"Summit Hotel Properties","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-30","payableDate":"2025-05-16","currency":"USD","dateTimestamp":1747368000000,"payDate":"2025-05-30"},{"date":"2025-04-30","symbol":"INN","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1746043200000,"name":null,"time":"Post Market","dateTimestamp":1745985600000,"actualEps":null},{"date":"2025-02-24","symbol":"INN","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2024/12","expectedEps":0.17,"defaultRemindTime":1740430800000,"name":null,"time":"Post Market","dateTimestamp":1740373200000,"actualEps":null},{"date":"2025-02-14","symbol":"INN","amount":0.08,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-02-14","defaultRemindTime":1739543400000,"name":"Summit Hotel Properties","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-02-28","payableDate":"2025-02-14","currency":"USD","dateTimestamp":1739509200000,"payDate":"2025-02-28"},{"date":"2024-11-15","symbol":"INN","amount":0.08,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-11-15","defaultRemindTime":1731681000000,"name":"Summit Hotel Properties","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-11-29","payableDate":"2024-11-15","currency":"USD","dateTimestamp":1731646800000,"payDate":"2024-11-29"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"INN\",market:\"US\",,,undefined,":[{"executeDate":"2015-05-13","recordDate":"2015-05-15","paymentDate":"2015-05-29","value":0.1175,"currency":"USD"},{"executeDate":"2015-08-12","recordDate":"2015-08-14","paymentDate":"2015-08-31","value":0.1175,"currency":"USD"},{"executeDate":"2015-11-12","recordDate":"2015-11-16","paymentDate":"2015-11-30","value":0.1175,"currency":"USD"},{"executeDate":"2016-02-11","recordDate":"2016-02-16","paymentDate":"2016-02-29","value":0.1175,"currency":"USD"},{"executeDate":"2016-05-12","recordDate":"2016-05-16","paymentDate":"2016-05-31","value":0.1325,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"INN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.3333,"hold":0.5,"sell":0.1667,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.5,"analysts":6,"updateTime":1704859200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/INN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"INN","date":"2025-04-25","current":10.106568,"percent":0.677236,"low":-486.144815,"twenty":-85.527199,"median":-9.629631,"eighty":27.443666,"high":28845.000692,"avg":1331.432479,"sd":5938.454772,"marketCap":441070846},"quantilePoints":[{"date":"2020-05-01","current":7.245492,"twenty":12.190349,"median":16.407962,"eighty":56.934583,"marketCap":598550084},{"date":"2020-05-08","current":7.577152,"twenty":12.16592,"median":16.354689,"eighty":44.66724,"marketCap":625948503},{"date":"2020-05-15","current":9.081235,"twenty":12.097861,"median":16.301417,"eighty":44.227602,"marketCap":494119100},{"date":"2020-05-22","current":10.617462,"twenty":12.042528,"median":16.261462,"eighty":43.40485,"marketCap":577706700},{"date":"2020-05-29","current":12.153688,"twenty":12.024822,"median":16.194871,"eighty":41.797031,"marketCap":661294300},{"date":"2020-06-05","current":15.595612,"twenty":12.024822,"median":16.141599,"eighty":40.650881,"marketCap":848572845},{"date":"2020-06-12","current":14.137169,"twenty":12.024822,"median":16.128281,"eighty":39.903648,"marketCap":769217529},{"date":"2020-06-19","current":11.842553,"twenty":12.016955,"median":16.101644,"eighty":39.282245,"marketCap":644365165},{"date":"2020-06-26","current":11.00638,"twenty":11.991623,"median":16.06169,"eighty":38.560261,"marketCap":598868118},{"date":"2020-07-02","current":11.064717,"twenty":11.91586,"median":16.035053,"eighty":38.390751,"marketCap":602042330},{"date":"2020-07-10","current":10.773029,"twenty":11.877622,"median":15.968463,"eighty":37.71514,"marketCap":586171267},{"date":"2020-07-17","current":10.559124,"twenty":11.824949,"median":15.923618,"eighty":37.348582,"marketCap":574532487},{"date":"2020-07-24","current":10.384111,"twenty":11.770376,"median":15.91519,"eighty":36.670545,"marketCap":565009849},{"date":"2020-07-31","current":10.072976,"twenty":11.731171,"median":15.861918,"eighty":36.143736,"marketCap":548080715},{"date":"2020-08-07","current":-14.26916,"twenty":11.678114,"median":15.76869,"eighty":35.732427,"marketCap":641584235},{"date":"2020-08-14","current":-14.551717,"twenty":11.657665,"median":15.662145,"eighty":35.569055,"marketCap":654288873},{"date":"2020-08-21","current":-13.327301,"twenty":11.571097,"median":15.595612,"eighty":35.348984,"marketCap":599235440},{"date":"2020-08-28","current":-14.716543,"twenty":11.531728,"median":15.528217,"eighty":35.068782,"marketCap":661699912},{"date":"2020-09-04","current":-14.245613,"twenty":11.513895,"median":15.475691,"eighty":34.915611,"marketCap":640525515},{"date":"2020-09-11","current":-12.974104,"twenty":11.464932,"median":15.422367,"eighty":34.769738,"marketCap":583354642},{"date":"2020-09-18","current":-13.704045,"twenty":11.354123,"median":15.34251,"eighty":34.46544,"marketCap":616174958},{"date":"2020-09-25","current":-11.631955,"twenty":11.305184,"median":15.302555,"eighty":34.221768,"marketCap":523007610},{"date":"2020-10-02","current":-12.691546,"twenty":11.23973,"median":15.182692,"eighty":33.856845,"marketCap":570650004},{"date":"2020-10-09","current":-12.927011,"twenty":11.065766,"median":15.089465,"eighty":33.522616,"marketCap":581237203},{"date":"2020-10-16","current":-12.102885,"twenty":10.948042,"median":15.062828,"eighty":33.452037,"marketCap":544182008},{"date":"2020-10-23","current":-13.704045,"twenty":10.808945,"median":14.872865,"eighty":33.323077,"marketCap":616174958},{"date":"2020-10-30","current":-12.432535,"twenty":10.707913,"median":14.684203,"eighty":33.033745,"marketCap":559004086},{"date":"2020-11-06","current":-6.757049,"twenty":10.677621,"median":14.548156,"eighty":32.933975,"marketCap":615182019},{"date":"2020-11-13","current":-8.792305,"twenty":10.602294,"median":14.406205,"eighty":32.749256,"marketCap":800477808},{"date":"2020-11-20","current":-9.594777,"twenty":10.559124,"median":14.239675,"eighty":32.649632,"marketCap":873537291},{"date":"2020-11-27","current":-10.58333,"twenty":10.512454,"median":14.186936,"eighty":32.539328,"marketCap":963538102},{"date":"2020-12-04","current":-11.188092,"twenty":10.360776,"median":14.081457,"eighty":32.363485,"marketCap":1018597422},{"date":"2020-12-11","current":-10.73452,"twenty":10.263185,"median":13.936714,"eighty":32.231442,"marketCap":977302932},{"date":"2020-12-18","current":-10.60659,"twenty":10.131357,"median":13.870137,"eighty":32.151544,"marketCap":965655768},{"date":"2020-12-24","current":-10.64148,"twenty":10.058473,"median":13.770272,"eighty":32.102465,"marketCap":968832268},{"date":"2020-12-31","current":-10.47866,"twenty":9.985663,"median":13.72,"eighty":32.011106,"marketCap":954008605},{"date":"2021-01-08","current":-10.013458,"twenty":9.95257,"median":13.637119,"eighty":31.858764,"marketCap":911655281},{"date":"2021-01-15","current":-10.292579,"twenty":9.884798,"median":13.596253,"eighty":31.690959,"marketCap":937067275},{"date":"2021-01-22","current":-10.187909,"twenty":9.831806,"median":13.553495,"eighty":31.427336,"marketCap":927537778},{"date":"2021-01-29","current":-9.420327,"twenty":9.781442,"median":13.464693,"eighty":31.271311,"marketCap":857654794},{"date":"2021-02-05","current":-10.246059,"twenty":9.751556,"median":13.37589,"eighty":31.064578,"marketCap":932831943},{"date":"2021-02-12","current":-11.269502,"twenty":9.636993,"median":13.298188,"eighty":30.998267,"marketCap":1026009254},{"date":"2021-02-19","current":-11.618403,"twenty":9.580956,"median":13.242686,"eighty":30.900752,"marketCap":1057774246},{"date":"2021-02-26","current":-7.644535,"twenty":9.455187,"median":13.142784,"eighty":30.756429,"marketCap":1095759975},{"date":"2021-03-05","current":-7.533744,"twenty":9.334891,"median":13.112023,"eighty":30.600404,"marketCap":1079879395},{"date":"2021-03-12","current":-7.947362,"twenty":9.228551,"median":13.062031,"eighty":30.319559,"marketCap":1139166892},{"date":"2021-03-19","current":-7.947362,"twenty":9.158817,"median":13.026833,"eighty":29.664254,"marketCap":1139166892},{"date":"2021-03-26","current":-7.792255,"twenty":9.131422,"median":13.011931,"eighty":29.106465,"marketCap":1116934080},{"date":"2021-04-01","current":-7.755325,"twenty":9.094461,"median":12.989689,"eighty":28.010389,"marketCap":1111640554},{"date":"2021-04-09","current":-7.371252,"twenty":9.013076,"median":12.942915,"eighty":27.639829,"marketCap":1056587879},{"date":"2021-04-16","current":-7.341708,"twenty":8.897742,"median":12.929423,"eighty":27.413593,"marketCap":1052353058},{"date":"2021-04-23","current":-7.363866,"twenty":8.859718,"median":12.914566,"eighty":25.631007,"marketCap":1055529174},{"date":"2021-04-30","current":-7.511586,"twenty":8.795192,"median":12.896128,"eighty":23.275869,"marketCap":1076703279},{"date":"2021-05-07","current":-6.681778,"twenty":8.759471,"median":12.881092,"eighty":21.189342,"marketCap":1064955219},{"date":"2021-05-14","current":-6.681778,"twenty":8.709924,"median":12.862833,"eighty":20.69341,"marketCap":1064955219},{"date":"2021-05-21","current":-6.281672,"twenty":8.638484,"median":12.841655,"eighty":20.491158,"marketCap":1001185445},{"date":"2021-05-28","current":-6.408372,"twenty":8.609678,"median":12.792354,"eighty":20.294447,"marketCap":1021379207},{"date":"2021-06-04","current":-6.46172,"twenty":8.4055,"median":12.775725,"eighty":20.139295,"marketCap":1029881843},{"date":"2021-06-11","current":-6.775137,"twenty":7.416425,"median":12.759113,"eighty":19.997996,"marketCap":1079834832},{"date":"2021-06-18","current":-6.395035,"twenty":6.684221,"median":12.749,"eighty":19.945355,"marketCap":1019253548},{"date":"2021-06-25","current":-6.601757,"twenty":6.046414,"median":12.72169,"eighty":19.817909,"marketCap":1052201264},{"date":"2021-07-02","current":-6.275004,"twenty":5.890789,"median":12.707458,"eighty":19.77635,"marketCap":1000122615},{"date":"2021-07-09","current":-6.108293,"twenty":5.829559,"median":12.698771,"eighty":19.693233,"marketCap":973551876},{"date":"2021-07-16","current":-5.921576,"twenty":5.337172,"median":12.682512,"eighty":19.601804,"marketCap":943792649},{"date":"2021-07-23","current":-6.048277,"twenty":4.870297,"median":12.663063,"eighty":19.38847,"marketCap":963986410},{"date":"2021-07-30","current":-6.008266,"twenty":4.331988,"median":12.635319,"eighty":18.865947,"marketCap":957609433},{"date":"2021-08-06","current":-7.582611,"twenty":-5.8869,"median":12.607336,"eighty":18.219581,"marketCap":967973418},{"date":"2021-08-13","current":-7.607664,"twenty":-6.02427,"median":12.593638,"eighty":18.08997,"marketCap":971171568},{"date":"2021-08-20","current":-7.248576,"twenty":-6.105625,"median":12.582035,"eighty":17.986811,"marketCap":925331417},{"date":"2021-08-27","current":-7.858191,"twenty":-6.181645,"median":12.56205,"eighty":17.915393,"marketCap":1003153068},{"date":"2021-09-03","current":-7.641068,"twenty":-6.225657,"median":12.517702,"eighty":17.801653,"marketCap":975435768},{"date":"2021-09-10","current":-7.373839,"twenty":-6.279005,"median":12.488206,"eighty":17.769911,"marketCap":941322167},{"date":"2021-09-17","current":-7.749629,"twenty":-6.373696,"median":12.451206,"eighty":17.73817,"marketCap":989294418},{"date":"2021-09-24","current":-8.284086,"twenty":-6.42571,"median":12.412426,"eighty":17.664107,"marketCap":1057521619},{"date":"2021-10-01","current":-8.342543,"twenty":-6.46172,"median":12.391158,"eighty":17.508044,"marketCap":1064983969},{"date":"2021-10-08","current":-8.309139,"twenty":-6.54841,"median":12.372235,"eighty":17.045149,"marketCap":1060719769},{"date":"2021-10-15","current":-8.509561,"twenty":-6.59909,"median":12.329316,"eighty":16.681492,"marketCap":1086304970},{"date":"2021-10-22","current":-8.434403,"twenty":-6.723123,"median":12.298582,"eighty":16.537284,"marketCap":1076710520},{"date":"2021-10-29","current":-8.350894,"twenty":-6.769802,"median":12.271537,"eighty":16.399383,"marketCap":1066050020},{"date":"2021-11-05","current":-11.507518,"twenty":-6.924522,"median":12.245349,"eighty":16.344035,"marketCap":1123306370},{"date":"2021-11-12","current":-10.841523,"twenty":-7.207282,"median":12.213867,"eighty":16.296089,"marketCap":1058295281},{"date":"2021-11-19","current":-10.284708,"twenty":-7.315383,"median":12.189061,"eighty":16.251047,"marketCap":1003941746},{"date":"2021-11-26","current":-9.749728,"twenty":-7.361174,"median":12.169733,"eighty":16.194323,"marketCap":951719724},{"date":"2021-12-03","current":-9.629631,"twenty":-7.400796,"median":12.117781,"eighty":16.141397,"marketCap":939996412},{"date":"2021-12-10","current":-10.317462,"twenty":-7.43531,"median":12.064233,"eighty":16.128281,"marketCap":1007139013},{"date":"2021-12-17","current":-9.749728,"twenty":-7.479061,"median":12.015115,"eighty":16.088326,"marketCap":951719724},{"date":"2021-12-23","current":-10.666836,"twenty":-7.523404,"median":11.990516,"eighty":16.056363,"marketCap":1041243191},{"date":"2021-12-31","current":-10.655918,"twenty":-7.553225,"median":11.897801,"eighty":16.020181,"marketCap":1040177436},{"date":"2022-01-07","current":-11.245487,"twenty":-7.60263,"median":11.874318,"eighty":15.960472,"marketCap":1097728237},{"date":"2022-01-14","current":-11.048964,"twenty":-7.638717,"median":11.824949,"eighty":15.918561,"marketCap":1078544636},{"date":"2022-01-21","current":-10.372051,"twenty":-7.662032,"median":11.77472,"eighty":15.91519,"marketCap":1012467791},{"date":"2022-01-28","current":-9.891662,"twenty":-7.683407,"median":11.731649,"eighty":15.888554,"marketCap":965574546},{"date":"2022-02-04","current":-10.339297,"twenty":-7.72721,"median":11.680109,"eighty":15.780318,"marketCap":1009270524},{"date":"2022-02-11","current":-10.75418,"twenty":-7.750768,"median":11.664003,"eighty":15.690782,"marketCap":1049769236},{"date":"2022-02-18","current":-11.223651,"twenty":-7.784877,"median":11.598826,"eighty":15.624855,"marketCap":1095596725},{"date":"2022-02-25","current":-16.333636,"twenty":-7.898187,"median":11.552326,"eighty":15.566323,"marketCap":1071045495},{"date":"2022-03-04","current":-15.846549,"twenty":-7.956251,"median":11.520191,"eighty":15.504991,"marketCap":1039105768},{"date":"2022-03-11","current":-16.236218,"twenty":-8.122216,"median":11.482784,"eighty":15.432952,"marketCap":1064657550},{"date":"2022-03-18","current":-16.431053,"twenty":-8.199454,"median":11.367652,"eighty":15.360915,"marketCap":1077433440},{"date":"2022-03-25","current":-16.041384,"twenty":-8.275736,"median":11.311409,"eighty":15.307464,"marketCap":1051881659},{"date":"2022-04-01","current":-16.511742,"twenty":-8.309139,"median":11.245326,"eighty":15.196365,"marketCap":1082724458},{"date":"2022-04-08","current":-14.644633,"twenty":-8.357575,"median":11.083066,"eighty":15.097163,"marketCap":960292489},{"date":"2022-04-14","current":-15.764898,"twenty":-8.427722,"median":11.016102,"eighty":15.08249,"marketCap":1033751671},{"date":"2022-04-22","current":-15.651248,"twenty":-8.514571,"median":10.849815,"eighty":15.011052,"marketCap":1026299290},{"date":"2022-04-29","current":-16.02467,"twenty":-9.315865,"median":10.741181,"eighty":14.780245,"marketCap":1050785684},{"date":"2022-05-06","current":-26.99761,"twenty":-9.515693,"median":10.706806,"eighty":14.701328,"marketCap":1150557134},{"date":"2022-05-13","current":-25.260481,"twenty":-9.679854,"median":10.706806,"eighty":14.701328,"marketCap":1076525930},{"date":"2022-05-20","current":-24.020526,"twenty":-9.754095,"median":10.698259,"eighty":14.701328,"marketCap":1023682763},{"date":"2022-05-27","current":-25.34699,"twenty":-9.874193,"median":10.598502,"eighty":14.701328,"marketCap":1080212663},{"date":"2022-06-03","current":-25.750696,"twenty":-9.992304,"median":10.559124,"eighty":14.701328,"marketCap":1097417415},{"date":"2022-06-10","current":-24.597249,"twenty":-10.097195,"median":10.41328,"eighty":14.701328,"marketCap":1048260980},{"date":"2022-06-17","current":-20.560186,"twenty":-10.14385,"median":10.296604,"eighty":14.701328,"marketCap":876213457},{"date":"2022-06-24","current":-21.165746,"twenty":-10.180931,"median":10.170206,"eighty":14.718453,"marketCap":902020585},{"date":"2022-07-01","current":-20.790876,"twenty":-10.209437,"median":10.086528,"eighty":14.718453,"marketCap":886044744},{"date":"2022-07-08","current":-21.021565,"twenty":-10.259762,"median":10.005587,"eighty":14.718453,"marketCap":895876031},{"date":"2022-07-15","current":-21.367599,"twenty":-10.292579,"median":9.955777,"eighty":14.718453,"marketCap":910622962},{"date":"2022-07-22","current":-21.425271,"twenty":-10.34387,"median":9.849931,"eighty":14.718453,"marketCap":913080783},{"date":"2022-07-29","current":-22.63639,"twenty":-10.382969,"median":9.781442,"eighty":14.718453,"marketCap":964695040},{"date":"2022-08-05","current":-92.692376,"twenty":-10.438674,"median":9.756537,"eighty":14.718453,"marketCap":1001541128},{"date":"2022-08-12","current":-100.994884,"twenty":-10.516564,"median":9.650691,"eighty":14.718453,"marketCap":1091249720},{"date":"2022-08-19","current":-97.469161,"twenty":-10.61322,"median":9.650691,"eighty":14.718453,"marketCap":1053154290},{"date":"2022-08-26","current":-94.057172,"twenty":-10.659447,"median":9.650691,"eighty":14.718453,"marketCap":1016287746},{"date":"2022-09-02","current":-86.891995,"twenty":-10.677754,"median":9.650691,"eighty":14.718453,"marketCap":938868002},{"date":"2022-09-09","current":-92.351178,"twenty":-10.712692,"median":9.650691,"eighty":14.718453,"marketCap":997854473},{"date":"2022-09-16","current":-88.825455,"twenty":-10.776126,"median":9.644465,"eighty":14.718453,"marketCap":959759044},{"date":"2022-09-23","current":-79.158152,"twenty":-10.834972,"median":9.625786,"eighty":14.718453,"marketCap":855303834},{"date":"2022-09-30","current":-76.428561,"twenty":-10.898297,"median":9.146158,"eighty":14.718453,"marketCap":825810599},{"date":"2022-10-07","current":-78.362021,"twenty":-10.980633,"median":9.027948,"eighty":14.718453,"marketCap":846701640},{"date":"2022-10-14","current":-81.205346,"twenty":-11.048964,"median":8.895438,"eighty":14.718453,"marketCap":877423761},{"date":"2022-10-21","current":-92.351178,"twenty":-11.121143,"median":8.855109,"eighty":14.718453,"marketCap":997854473},{"date":"2022-10-28","current":-96.445565,"twenty":-11.232385,"median":8.785974,"eighty":14.718453,"marketCap":1042094327},{"date":"2022-11-04","current":-444.699289,"twenty":-11.298005,"median":8.757167,"eighty":14.718453,"marketCap":975670241},{"date":"2022-11-11","current":-472.703023,"twenty":-11.452091,"median":8.705315,"eighty":14.718453,"marketCap":1037110432},{"date":"2022-11-18","current":-479.423919,"twenty":-11.623824,"median":8.641941,"eighty":14.718453,"marketCap":1051856078},{"date":"2022-11-25","current":-474.943321,"twenty":-11.823023,"median":8.618896,"eighty":14.718453,"marketCap":1042025647},{"date":"2022-12-02","current":-466.542201,"twenty":-12.159396,"median":8.317008,"eighty":14.718453,"marketCap":1023593590},{"date":"2022-12-09","current":-442.45899,"twenty":-12.343059,"median":7.309273,"eighty":14.718453,"marketCap":970755025},{"date":"2022-12-16","current":-425.65675,"twenty":-12.512594,"median":6.684221,"eighty":14.718453,"marketCap":933890910},{"date":"2022-12-23","current":-404.933988,"twenty":-12.837535,"median":5.995389,"eighty":14.718453,"marketCap":888425169},{"date":"2022-12-30","current":-404.373913,"twenty":-12.959976,"median":5.906096,"eighty":14.718453,"marketCap":887196365},{"date":"2023-01-06","current":-412.214958,"twenty":-13.360266,"median":5.829559,"eighty":14.585019,"marketCap":904399618},{"date":"2023-01-13","current":-421.736227,"twenty":-13.558056,"median":5.383094,"eighty":14.414673,"marketCap":925289283},{"date":"2023-01-20","current":-436.298169,"twenty":-13.675789,"median":5.127971,"eighty":14.294316,"marketCap":957238183},{"date":"2023-01-27","current":-467.102276,"twenty":-13.831195,"median":4.528432,"eighty":14.195697,"marketCap":1024822394},{"date":"2023-02-03","current":-483.904516,"twenty":-14.085498,"median":-5.628165,"eighty":14.135385,"marketCap":1061686509},{"date":"2023-02-10","current":-451.98026,"twenty":-14.287997,"median":-6.008266,"eighty":13.964455,"marketCap":991644690},{"date":"2023-02-17","current":-443.57914,"twenty":-14.588883,"median":-6.094956,"eighty":13.878937,"marketCap":973212633},{"date":"2023-02-24","current":-442.45899,"twenty":-14.87518,"median":-6.114961,"eighty":13.790245,"marketCap":970755025},{"date":"2023-03-03","current":649.595817,"twenty":-14.87518,"median":-6.114961,"eighty":13.836849,"marketCap":952307468},{"date":"2023-03-10","current":588.408082,"twenty":-14.87518,"median":-6.114961,"eighty":13.934957,"marketCap":862606248},{"date":"2023-03-17","current":538.116793,"twenty":-14.87518,"median":-6.114961,"eighty":13.934957,"marketCap":788879218},{"date":"2023-03-24","current":543.145922,"twenty":-14.87518,"median":-6.114961,"eighty":13.981602,"marketCap":796251921},{"date":"2023-03-31","current":586.731706,"twenty":-14.865438,"median":-6.111627,"eighty":14.148636,"marketCap":860148681},{"date":"2023-04-06","current":557.39512,"twenty":-14.865438,"median":-6.111627,"eighty":14.148636,"marketCap":817141246},{"date":"2023-04-14","current":565.777002,"twenty":-14.87518,"median":-6.114961,"eighty":14.102167,"marketCap":829429085},{"date":"2023-04-21","current":550.689615,"twenty":-14.87518,"median":-6.114961,"eighty":14.102167,"marketCap":807310976},{"date":"2023-04-28","current":520.514842,"twenty":-14.87518,"median":-6.114961,"eighty":14.102167,"marketCap":763074758},{"date":"2023-05-05","current":93.586274,"twenty":-14.87518,"median":-6.114961,"eighty":14.102167,"marketCap":815978727},{"date":"2023-05-12","current":95.143686,"twenty":-14.87518,"median":-6.114961,"eighty":14.102167,"marketCap":829557798},{"date":"2023-05-19","current":98.400092,"twenty":-14.87518,"median":-6.114961,"eighty":14.102167,"marketCap":857950401},{"date":"2023-05-26","current":90.754617,"twenty":-14.87518,"median":-6.114961,"eighty":14.102167,"marketCap":791289507},{"date":"2023-06-02","current":93.86944,"twenty":-14.87518,"median":-6.114961,"eighty":14.102167,"marketCap":818447649},{"date":"2023-06-09","current":100.948584,"twenty":-14.87518,"median":-6.114961,"eighty":14.102167,"marketCap":880170700},{"date":"2023-06-16","current":91.88728,"twenty":-14.87518,"median":-6.114961,"eighty":14.102167,"marketCap":801165195},{"date":"2023-06-23","current":87.498211,"twenty":-14.884921,"median":-6.131632,"eighty":14.063275,"marketCap":762896904},{"date":"2023-06-30","current":92.170446,"twenty":-14.894663,"median":-6.148303,"eighty":14.020494,"marketCap":803634117},{"date":"2023-07-07","current":91.88728,"twenty":-14.894663,"median":-6.148303,"eighty":14.020494,"marketCap":801165195},{"date":"2023-07-14","current":93.019943,"twenty":-14.894663,"median":-6.148303,"eighty":14.020494,"marketCap":811040883},{"date":"2023-07-21","current":90.188286,"twenty":-14.894663,"median":-6.148303,"eighty":14.020494,"marketCap":786351663},{"date":"2023-07-28","current":85.9408,"twenty":-14.894663,"median":-6.148303,"eighty":14.020494,"marketCap":749317833},{"date":"2023-08-04","current":27514.424038,"twenty":-14.894663,"median":-6.148303,"eighty":14.020494,"marketCap":715375025},{"date":"2023-08-11","current":27989.63,"twenty":-14.894663,"median":-6.148303,"eighty":14.020494,"marketCap":727730380},{"date":"2023-08-18","current":26231.368,"twenty":-14.894663,"median":-6.148303,"eighty":14.020494,"marketCap":682015568},{"date":"2023-08-25","current":26183.847385,"twenty":-14.894663,"median":-6.148303,"eighty":14.020494,"marketCap":680780032},{"date":"2023-09-01","current":27609.465231,"twenty":-14.894663,"median":-6.148303,"eighty":14.020494,"marketCap":717846096},{"date":"2023-09-08","current":27609.465231,"twenty":-14.894663,"median":-6.148303,"eighty":14.020494,"marketCap":717846096},{"date":"2023-09-15","current":26849.135731,"twenty":-14.894663,"median":-6.148303,"eighty":14.020494,"marketCap":698077529},{"date":"2023-09-22","current":26326.409192,"twenty":-14.894663,"median":-6.148303,"eighty":14.020494,"marketCap":684486639},{"date":"2023-09-29","current":27799.547615,"twenty":-14.894663,"median":-6.148303,"eighty":14.020494,"marketCap":722788238},{"date":"2023-10-06","current":28037.150577,"twenty":-14.894663,"median":-6.148303,"eighty":14.020494,"marketCap":728965915},{"date":"2023-10-13","current":28037.150577,"twenty":-14.894663,"median":-6.148303,"eighty":14.020494,"marketCap":728965915},{"date":"2023-10-20","current":27276.821077,"twenty":-14.894663,"median":-6.148303,"eighty":14.020494,"marketCap":709197348},{"date":"2023-10-27","current":26896.656308,"twenty":-14.904608,"median":-6.181645,"eighty":13.919909,"marketCap":699313064},{"date":"2023-11-03","current":-154.971982,"twenty":-15.057511,"median":-6.198317,"eighty":13.981602,"marketCap":758587851},{"date":"2023-11-10","current":-149.166842,"twenty":-15.557081,"median":-6.254999,"eighty":13.981602,"marketCap":730171694},{"date":"2023-11-17","current":-156.991161,"twenty":-15.722685,"median":-6.321682,"eighty":13.981602,"marketCap":768471732},{"date":"2023-11-24","current":-158.342421,"twenty":-15.820383,"median":-6.408372,"eighty":13.981602,"marketCap":775086152},{"date":"2023-12-01","current":-137.577667,"twenty":-15.852855,"median":-6.451717,"eighty":13.981602,"marketCap":673442680},{"date":"2023-12-08","current":-139.995166,"twenty":-15.979686,"median":-6.468388,"eighty":13.962156,"marketCap":685276338},{"date":"2023-12-15","current":-147.906981,"twenty":-16.044631,"median":-6.568415,"eighty":13.962156,"marketCap":724004671},{"date":"2023-12-22","current":-145.489482,"twenty":-16.239465,"median":-6.648436,"eighty":13.962156,"marketCap":712171013},{"date":"2023-12-29","current":-150.32448,"twenty":-16.278433,"median":-6.69845,"eighty":14.020494,"marketCap":735838328},{"date":"2024-01-05","current":-146.1488,"twenty":-16.333636,"median":-6.757049,"eighty":14.03994,"marketCap":715398374},{"date":"2024-01-12","current":-144.830164,"twenty":-16.593415,"median":-6.775137,"eighty":14.03994,"marketCap":708943652},{"date":"2024-01-19","current":-141.753347,"twenty":-20.537117,"median":-7.08607,"eighty":14.047718,"marketCap":693882634},{"date":"2024-01-26","current":-147.906981,"twenty":-20.877384,"median":-7.248576,"eighty":14.03994,"marketCap":724004671},{"date":"2024-02-02","current":-145.709254,"twenty":-21.021565,"median":-7.341708,"eighty":14.03994,"marketCap":713246800},{"date":"2024-02-09","current":-144.830164,"twenty":-21.252254,"median":-7.371252,"eighty":14.03994,"marketCap":708943652},{"date":"2024-02-16","current":-144.390619,"twenty":-21.713633,"median":-7.408182,"eighty":14.03994,"marketCap":706792078},{"date":"2024-02-23","current":-146.808118,"twenty":-22.290356,"median":-7.445112,"eighty":14.03994,"marketCap":718625736},{"date":"2024-03-01","current":-72.784832,"twenty":-22.682528,"median":-7.493301,"eighty":14.020494,"marketCap":690655273},{"date":"2024-03-08","current":-71.547495,"twenty":-24.289478,"median":-7.530506,"eighty":14.020494,"marketCap":678914183},{"date":"2024-03-15","current":-71.547495,"twenty":-24.966353,"median":-7.587722,"eighty":14.020494,"marketCap":678914183},{"date":"2024-03-22","current":-73.58847,"twenty":-25.254714,"median":-7.607664,"eighty":14.020494,"marketCap":698280990},{"date":"2024-03-28","current":-73.361695,"twenty":-25.646886,"median":-7.642802,"eighty":14.020494,"marketCap":696129123},{"date":"2024-04-05","current":-70.980558,"twenty":-26.391246,"median":-7.674079,"eighty":14.03994,"marketCap":673534514},{"date":"2024-04-12","current":-74.835732,"twenty":-27.632848,"median":-7.707875,"eighty":14.03994,"marketCap":710116261},{"date":"2024-04-19","current":-69.619908,"twenty":-70.867171,"median":-7.733167,"eighty":14.03994,"marketCap":660623310},{"date":"2024-04-26","current":-68.826196,"twenty":-71.071268,"median":-7.768683,"eighty":14.020494,"marketCap":653091774},{"date":"2024-05-03","current":-104.849903,"twenty":-71.547495,"median":-7.841489,"eighty":14.020494,"marketCap":668627833},{"date":"2024-05-10","current":-103.831943,"twenty":-71.887658,"median":-7.939522,"eighty":14.020494,"marketCap":662136300},{"date":"2024-05-17","current":-102.983643,"twenty":-72.341208,"median":-8.075315,"eighty":14.020494,"marketCap":656726690},{"date":"2024-05-24","current":-102.135343,"twenty":-72.794758,"median":-8.191181,"eighty":14.020494,"marketCap":651317080},{"date":"2024-05-31","current":-102.135343,"twenty":-73.31634,"median":-8.208928,"eighty":14.020494,"marketCap":651317080},{"date":"2024-06-07","current":-103.492623,"twenty":-74.178085,"median":-8.279911,"eighty":14.020494,"marketCap":659972456},{"date":"2024-06-14","current":-100.099422,"twenty":-74.835732,"median":-8.309277,"eighty":14.03994,"marketCap":638334015},{"date":"2024-06-21","current":-100.438742,"twenty":-76.724267,"median":-8.392648,"eighty":14.047718,"marketCap":640497859},{"date":"2024-06-28","current":-98.742142,"twenty":-77.952582,"median":-8.434403,"eighty":14.071054,"marketCap":629678638},{"date":"2024-07-05","current":-98.572482,"twenty":-79.135405,"median":-8.509561,"eighty":14.071054,"marketCap":628596716},{"date":"2024-07-12","current":-98.911802,"twenty":-81.023373,"median":-9.31301,"eighty":14.071054,"marketCap":630760560},{"date":"2024-07-15","current":-99.929762,"twenty":-81.660278,"median":-9.327286,"eighty":14.071054,"marketCap":637252093},{"date":"2024-08-02","current":26.627657,"twenty":-85.390719,"median":-9.571517,"eighty":14.844411,"marketCap":671682660},{"date":"2024-08-09","current":27.143032,"twenty":-85.390719,"median":-9.571517,"eighty":15.188019,"marketCap":684682970},{"date":"2024-08-16","current":28.17378,"twenty":-85.390719,"median":-9.571517,"eighty":15.385128,"marketCap":710683589},{"date":"2024-08-23","current":28.860945,"twenty":-85.390719,"median":-9.571517,"eighty":15.5263,"marketCap":728017335},{"date":"2024-08-30","current":28.946841,"twenty":-85.390719,"median":-9.571517,"eighty":15.642885,"marketCap":730184053},{"date":"2024-09-06","current":27.830197,"twenty":-85.390719,"median":-9.571517,"eighty":15.704764,"marketCap":702016716},{"date":"2024-09-13","current":27.658406,"twenty":-85.390719,"median":-9.571517,"eighty":15.888554,"marketCap":697683279},{"date":"2024-09-20","current":29.934641,"twenty":-85.390719,"median":-9.571517,"eighty":15.91519,"marketCap":755101313},{"date":"2024-09-27","current":29.762849,"twenty":-85.390719,"median":-9.571517,"eighty":15.979117,"marketCap":750767877},{"date":"2024-10-04","current":29.676954,"twenty":-85.390719,"median":-9.571517,"eighty":16.053699,"marketCap":748601158},{"date":"2024-10-11","current":28.431467,"twenty":-85.390719,"median":-9.571517,"eighty":16.093653,"marketCap":717183744},{"date":"2024-10-18","current":28.259675,"twenty":-85.390719,"median":-9.571517,"eighty":16.128281,"marketCap":712850307},{"date":"2024-10-25","current":26.928292,"twenty":-85.390719,"median":-9.571517,"eighty":16.173562,"marketCap":679266174},{"date":"2024-10-31","current":27.357771,"twenty":-85.390719,"median":-9.571517,"eighty":16.229498,"marketCap":690099765},{"date":"2024-11-08","current":26.292029,"twenty":-85.436213,"median":-9.594777,"eighty":16.296089,"marketCap":693872947},{"date":"2024-11-15","current":25.922298,"twenty":-85.436213,"median":-9.594777,"eighty":16.375998,"marketCap":684115358},{"date":"2024-11-22","current":25.593647,"twenty":-85.436213,"median":-9.594777,"eighty":24.944563,"marketCap":675441947},{"date":"2024-11-29","current":27.031493,"twenty":-85.436213,"median":-9.594777,"eighty":25.405234,"marketCap":713388123},{"date":"2024-12-06","current":27.770956,"twenty":-85.436213,"median":-9.594777,"eighty":26.21219,"marketCap":732903300},{"date":"2024-12-13","current":27.606631,"twenty":-85.436213,"median":-9.594777,"eighty":26.648119,"marketCap":728566594},{"date":"2024-12-20","current":27.483387,"twenty":-85.436213,"median":-9.594777,"eighty":26.756501,"marketCap":725314065},{"date":"2024-12-27","current":28.592582,"twenty":-85.436213,"median":-9.594777,"eighty":26.891816,"marketCap":754586830},{"date":"2025-01-03","current":27.770956,"twenty":-85.436213,"median":-9.594777,"eighty":27.01506,"marketCap":732903300},{"date":"2025-01-10","current":26.826086,"twenty":-85.481706,"median":-9.612204,"eighty":27.057136,"marketCap":707967241},{"date":"2025-01-17","current":27.56555,"twenty":-85.481706,"median":-9.612204,"eighty":27.17739,"marketCap":727482418},{"date":"2025-01-24","current":27.647712,"twenty":-85.481706,"median":-9.612204,"eighty":27.222305,"marketCap":729650771},{"date":"2025-01-31","current":27.770956,"twenty":-85.481706,"median":-9.612204,"eighty":27.359669,"marketCap":732903300},{"date":"2025-02-07","current":27.770956,"twenty":-85.481706,"median":-9.612204,"eighty":27.393008,"marketCap":732903300},{"date":"2025-02-14","current":27.031493,"twenty":-85.481706,"median":-9.612204,"eighty":27.435178,"marketCap":713388123},{"date":"2025-02-21","current":26.743924,"twenty":-85.481706,"median":-9.612204,"eighty":27.435178,"marketCap":705798888},{"date":"2025-02-28","current":15.923126,"twenty":-85.481706,"median":-9.612204,"eighty":27.435178,"marketCap":694917065},{"date":"2025-03-07","current":16.224986,"twenty":-85.527199,"median":-9.629631,"eighty":27.443666,"marketCap":708090849},{"date":"2025-03-14","current":13.860415,"twenty":-85.527199,"median":-9.629631,"eighty":27.443666,"marketCap":604896213},{"date":"2025-03-21","current":14.262895,"twenty":-85.527199,"median":-9.629631,"eighty":27.443666,"marketCap":622461258},{"date":"2025-03-28","current":13.684329,"twenty":-85.527199,"median":-9.629631,"eighty":27.443666,"marketCap":597211506},{"date":"2025-04-04","current":11.546153,"twenty":-85.527199,"median":-9.629631,"eighty":27.443666,"marketCap":503897208},{"date":"2025-04-11","current":10.162627,"twenty":-85.481706,"median":-9.612204,"eighty":27.435178,"marketCap":443517369},{"date":"2025-04-17","current":9.709837,"twenty":-85.481706,"median":-9.612204,"eighty":27.435178,"marketCap":423756694},{"date":"2025-04-25","current":10.106568,"twenty":-85.527199,"median":-9.629631,"eighty":27.443666,"marketCap":441070846}],"updateTime":1745853547655}}}